Ponatinib
- PDF / 168,863 Bytes
- 1 Pages / 595.245 x 841.846 pts (A4) Page_size
- 41 Downloads / 159 Views
1 S
Cerebral haemorrhage: case report A multi-centre, observational retrospective analysis (Observatory of Ponatinib in Acute Lymphoblastic leukaemia; OPAL study) of 29 patients described a patient [age and sex not stated], who experienced a fatal cerebral haemorrhage during treatment with ponatinib for relapsed/refractory Philadelphia chromosome-positive acute lymphoblastic leukaemia [dosage, route and duration of treatment to reaction onset not stated]. Tavitian S, et al. Ponatinib-based therapy in adults with relapsed or refractory Philadelphia chromosome-positive acute lymphoblastic leukemia: results of the real-life OPAL 803507958 study. Leukemia and Lymphoma 61: 2161-2167, No. 9, 28 Jul 2020. Available from: URL: http://doi.org/10.1080/10428194.2020.1762876
0114-9954/20/1826-0001/$14.95 Adis © 2020 Springer Nature Switzerland AG. All rights reserved
Reactions 17 Oct 2020 No. 1826
Data Loading...
